Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01445
|
|||||
| Drug Name |
Hypericin
|
|||||
| Synonyms |
Hypericin; VIMRxyn; Synthetic hypericin, Nexell
|
|||||
| Indication | Subclinical anxious adults [ICD11: 6A73] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C30H16O8
|
|||||
| Canonical SMILES |
CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O
|
|||||
| InChI |
InChI=1S/C30H16O8/c1-7-3-9(31)19-23-15(7)16-8(2)4-10(32)20-24(16)28-26-18(12(34)6-14(36)22(26)30(20)38)17-11(33)5-13(35)21(29(19)37)25(17)27(23)28/h3-6,33-38H,1-2H3
|
|||||
| InChIKey |
YDOIFHVUBCIUHF-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 548-04-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 504.4 | Topological Polar Surface Area | 156 | ||
| Heavy Atom Count | 38 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 8 | |||
| XLogP |
5.7
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT02862236) The Acute Effect of Hypericum Perforatum on Short-Term Memory in Healthy Adults | |||||
| 2 | Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells. Photochem Photobiol Sci. 2009 Dec;8(12):1716-23. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.